June 20, 2025: The Influx Healthtech IPO GMP, which opened on June 18 and closes today, is drawing significant investor attention with a promising start. On its first day, the issue was subscribed 1.72 times, reflecting robust interest from retail and non-institutional investors.
Priced between ₹91 and ₹96 per share, the IPO aims to raise approximately ₹55 to ₹59 crore through a combination of fresh issuance and offer-for-sale shares. Market observers are optimistic about the stock’s listing prospects given the early subscription success.
While grey market premium (GMP) data—an unofficial indicator of expected listing gains—is yet to be reported today, previous signals suggest a strong listing pop is likely. Investors typically watch GMP closely as a gauge of aftermarket demand, especially for SME IPOs like Influx Healthtech.
Analysts caution that GMP figures can be volatile and unofficial, urging investors to consider them alongside fundamental company details and market conditions. The official listing on the NSE SME platform is expected around June 25.
With growing investor enthusiasm, Influx Healthtech’s debut is shaping up to be one of the more watched SME IPOs in recent weeks.